輸入代號或公司名稱後按 Enter
4111

濟生

-0.15 (-0.52%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
28.809成交張數9.11本益比1.23股價淨值比4.51%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.7427.4%3.160.4411.8%3.13%14.04%
2026Q10.9039.0%3.000.5415.1%3.83%13.06%
2025Q40.77-1.4%2.750.4613.2%3.36%12.37%
2025Q30.75125.4%2.760.4513.2%3.44%12.91%
2025Q20.5869.5%2.340.359.4%2.67%11.25%
2025Q10.6565.8%2.100.3912.1%3.00%9.88%
2024Q40.78485.4%1.850.4714.1%3.74%8.87%
2024Q30.33-7.9%1.200.207.1%1.66%5.86%
2024Q20.340.0%1.230.217.3%1.68%6.10%
2024Q10.3924.2%1.230.238.7%1.88%5.89%
2023Q40.13-85.3%1.150.082.8%0.62%5.63%
2023Q30.36-54.2%1.920.228.3%1.82%9.77%
2023Q20.34-21.8%2.350.217.7%1.69%12.28%
2023Q10.31-28.3%2.450.197.1%1.52%12.35%
2022Q40.9058.3%2.570.5418.8%4.58%13.26%
2022Q30.79112.8%2.240.4716.3%4.18%12.03%
2022Q20.44119.0%1.820.269.4%2.36%9.89%
2022Q10.44109.1%1.580.269.3%2.34%8.48%
2021Q40.57275.0%1.350.3412.1%3.13%7.42%
2021Q30.37178.6%0.930.228.3%2.06%5.21%
2021Q20.20-25.0%0.700.124.6%1.08%3.86%
2021Q10.21-52.2%0.760.135.3%1.18%4.21%
2020Q40.15-56.8%0.990.093.6%0.82%5.51%
2020Q30.13-51.7%1.190.083.5%0.78%6.78%
2020Q20.27-24.3%1.330.166.9%1.52%7.62%
2020Q10.4491.6%1.420.269.8%2.40%7.85%
2019Q40.35236.3%1.210.218.0%2.01%6.84%
2019Q30.283.6%0.960.166.4%1.56%5.49%
2019Q20.35105.5%0.950.218.1%1.98%5.49%
2019Q10.2341.2%0.770.145.7%1.29%4.35%
2018Q40.10-60.7%0.700.062.6%0.61%4.03%
2018Q30.27-33.3%0.870.166.6%1.56%5.04%
2018Q20.17-48.6%1.000.104.4%0.99%5.91%
2018Q10.16-55.3%1.160.093.9%0.89%6.62%
2017Q40.27-39.1%1.360.166.3%1.56%7.88%
2017Q30.4013.5%1.530.248.8%2.35%8.96%
2017Q20.3320.7%1.490.207.8%1.92%8.86%
2017Q10.36137.5%1.430.228.4%2.12%8.36%
2016Q40.441.220.2610.4%2.56%
2016Q30.350.218.4%2.13%